Carr Patricia's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Nov 20, 2025
- Accession no.
- 0001784606-25-000004
- Filed
- Nov 20, 2025
- Trade date
- Nov 18, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $968.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carr PatriciaCIK 0001784606 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Ordinary Shares | SSaleDisposed | −69 | $181.66 | −$12,534.54 | 7,012 | Direct | |
| Nov 18, 2025 | Ordinary Shares | MOption exerciseAcquired | +5,250 | $136.18 | +$714,945 | 12,262 | Direct | |
| Nov 18, 2025 | Ordinary Shares | SSaleDisposed | −5,250 | $182.07 | −$955,867.5 | 7,012 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Ordinary Shares | MOption exerciseDisposed | −5,250 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.